In recent months, a joint report from the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) has shed light on an alarming trend: the resurgence of measles, a highly contagious viral disease. The report, published on November 17, indicates that approximately 22 million children, eligible for measles vaccinations in 2022, did not receive them. This significant gap in immunization has not only made a vast number of children vulnerable to infection but has also led to an increase in the risk of outbreaks and fatalities.
According to WHO data released on November 16, global measles cases surged by 18% in 2022, with deaths increasing by an alarming 43% from the previous year. These numbers are particularly concerning as measles predominantly affects children. John Vertefeuille, PhD, the director of CDC’s global immunization division, describes these findings as “staggering,” attributing the rise in cases to a decline in vaccination rates over the past few years.
This issue is not confined to lower-income countries, which typically witness higher rates of measles infections and deaths due to lower vaccination rates. The pandemic has exacerbated the situation even in countries like the United States, where there has been a notable lag in keeping up to date with basic vaccinations among children.
Kate O’Brien, MD, the WHO’s director for immunization, vaccines, and biologicals, emphasizes the urgent need for action, particularly in low-income countries. She refers to measles as “the inequity virus,” highlighting its propensity to target and affect those who are unprotected.
Given this context, it becomes increasingly important for individuals, especially parents and caregivers, to remain vigilant in monitoring for symptoms of measles. Early detection is crucial in managing and containing the spread of the disease. One of the primary symptoms of measles is a high fever, which often precedes the characteristic rash.
In such scenarios, having a reliable, easy-to-use, and accurate thermometer is essential. The Exergen Temporal Artery Thermometer emerges as a particularly suitable choice. Its non-invasive nature makes it ideal for use with children, providing a quick and precise reading of body temperature. Monitoring body temperature twice daily with such a thermometer can be a critical step in early symptom detection, especially in households with children who have not received the measles vaccine.
Regular temperature checks can help in identifying fever early, which is vital in seeking timely medical advice and potentially curtailing the spread of measles. Given the current rise in measles cases and the associated risks, investing in a dependable thermometer like the Exergen Temporal Artery Thermometer is a prudent step towards ensuring the health and safety of your family.
The resurgence of measles is a pressing global health concern. The declining vaccination rates highlight the need for heightened vigilance. Regular monitoring of body temperature with a reliable thermometer is a simple yet effective measure in this direction. By staying alert and prepared, we can collectively contribute to mitigating the impact of this preventable yet dangerous disease.
Source,
EXERGEN P/N 850209, Rev 1